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Introduction: TMJ arthritis occurs in up to 80% of children with JIA and it has been 
described in all JIA subtypes. TMJ arthritis can develop anytime during the course of 
JIA, even when patients are asymptomatic or on biologic therapy. As it can also occur 
in the absence of clinically evident arthritis outside the TMJ, a precocious evaluation by 
maxillofacial surgery is suggested. 
Objectives: Evaluation of TMJ in JIA and presentation of adopted guidelines in Centro 
Hospitalar do Porto. 
Methods: Selection of three polyarticular JIA cases with TMJ involvement followed in 
pediatric rheumatology unit. The protocol establishes oral-maxillofacial observation 
and high-resolution ultrasound at clinical presentation of polyarticular JIA. The need of 
contrast-enhanced magnetic resonance imaging, the periodicity of clinical observations 
and the decision to perform intraarticular corticosteroids injections is based on the 
clinical repercussion of TMJ arthritis. 
Results: Case 1: 15 year old girl, with polyarticular JIA diagnosed in 2012 and on 
etanercept during the past 14 months. The TMJ response to biologic therapy was 
minimal and maximal incisional opening (MIO) was 37mm.Intraarticular corticosteroid 
injection (triamcinolone hexacetonide -1ml; 20mg/ml) was performed and three 
months after arthroscopy, pain relief was achieved with a good MIO improvement. 
Case 2: 11 year old girl, with psoriatic JIA diagnosed in 2008, on etanercept during the 
past 22 months and intolerant to methotrexat. She has micrognathia, malocclusion of 
the teeth with overbite (class 2) and a painful TMJ. Condylar flattening was observed in 
the last magnetic resonance imaging. 
Case 3: 14 year old girl, with polyarticular JIA diagnosed in 2012 and on etanercept 
during the past 12 months. Facial asymmetry and sporadic pain when opening the 
mouth were present. TM joint dysfunction with limited left condylar excursion was 
confirmed in the last high-resolution ultrasound. 
Conclusions: The TMJ involvement in JIA, presented in the cases, was responsible for 
the recent creation of a multidisciplinary protocol joining pediatric rheumatology and 
oral-maxillofacial surgery of Centro Hospitalar do Porto. The main goal is to guarantee 
a precocious TMJ examination, with early treatment when necessary, to avoid some 
deleterious consequences that develop even in the absence of symptoms.  
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